The evolution of HIV treatment guidelines: Current state-of-the-art of ART

被引:49
作者
Zolopa, Andrew R. [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Med, Div Infect Dis & Geog Med, Palo Alto, CA 94305 USA
关键词
HIV treatment guidelines; ANTIRETROVIRAL THERAPY; CONTROLLED-TRIAL; OPPORTUNISTIC INFECTIONS; DOUBLE-BLIND; AIDS; RECOMMENDATIONS; MULTICENTER; PREVENTION; INDINAVIR; EFFICACY;
D O I
10.1016/j.antiviral.2009.10.018
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Expert panels have provided guidelines for the treatment of HIV infection for more than a decade. The guidelines have evolved rapidly reflecting the remarkable improvements in HIV therapeutics over this time. From guidelines based mostly on expert opinion - the Current guidelines are now primarily evidence-based recommendations - which the vast majority of treating clinicians accept and follow. We will highlight the major guideline recommendations for initiation of antiretroviral therapy - focusing on new data for the asymptomatic patient and those presenting with acute AIDS-related opportunistic infections. Given the number of new drugs available, we are currently able to offer virtually all patients in practice - a fully suppressive regimen, even in patients with Substantial multi-drug resistant HIV. A remarkable achievement since AZT was first introduced for the treatment of HIV. This article forms part of a special issue of Antiviral Research marking the 25th anniversary of antiretroviral drug discovery and development, vol. 85, issue 1, 2010. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:241 / 244
页数:4
相关论文
共 23 条
[1]  
ABDOOL K, 2009, 16 C RETR OPP INF FE
[2]  
*AIDS INF, 2008, GUID US ANT AG 1 HIV
[3]  
[Anonymous], 5 IAS C HIV PATH TRE
[4]  
[Anonymous], 2009, Guide to Workplace Health Safety Committees, P1
[5]   Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease [J].
Cameron, DW ;
Heath-Chiozzi, M ;
Danner, S ;
Cohen, C ;
Kravcik, S ;
Maurath, C ;
Sun, E ;
Henry, D ;
Rode, R ;
Potthoff, A ;
Leonard, J .
LANCET, 1998, 351 (9102) :543-549
[6]   Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration [J].
Detels, R ;
Muñoz, A ;
McFarlane, G ;
Kingsley, LA ;
Margolick, JB ;
Giorgi, J ;
Scharager, LD ;
Phair, JP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (17) :1497-1503
[7]   Universal Voluntary Testing and Treatment for Prevention of HIV Transmission [J].
Dieffenbach, Carl W. ;
Fauci, Anthony S. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (22) :2380-2382
[8]  
El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360
[9]   THE EFFICACY OF AZIDOTHYMIDINE (AZT) IN THE TREATMENT OF PATIENTS WITH AIDS AND AIDS-RELATED COMPLEX - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
FISCHL, MA ;
RICHMAN, DD ;
GRIECO, MH ;
GOTTLIEB, MS ;
VOLBERDING, PA ;
LASKIN, OL ;
LEEDOM, JM ;
GROOPMAN, JE ;
MILDVAN, D ;
SCHOOLEY, RT ;
JACKSON, GG ;
DURACK, DT ;
KING, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (04) :185-191
[10]   Late diagnosis of HIV infection: Epidemiological features, consequences and strategies to encourage earlier testing [J].
Girardi, Enrico ;
Sabin, Caroline A. ;
Monforte, Antonella d'Arminio .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 46 :S3-S8